Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria – 2017

Background Nigeria reports high rates of mortality linked with recurring meningococcal meningitis outbreaks within the African meningitis belt. Few studies have thoroughly described the response to these outbreaks to provide strong and actionable public health messages. We describe how time delays affected the response to the 2016/2017 meningococcal meningitis outbreak in Nigeria. Methods Using data from Nigeria Centre for Disease Control (NCDC), National Primary Health Care Development Agency (NPHCDA), World Health Organisation (WHO), and situation reports of rapid response teams, we calculated attack and death rates of reported suspected meningococcal meningitis cases per week in Zamfara, Sokoto and Yobe states respectively, between epidemiological week 49 in 2016 and epidemiological week 25 in 2017. We identified when alert and epidemic thresholds were crossed and determined when the outbreak was detected and notified in each state. We examined response activities to the outbreak. Results There were 12,535 suspected meningococcal meningitis cases and 877 deaths (CFR: 7.0%) in the three states. It took an average time of three weeks before the outbreaks were detected and notified to NCDC. Four weeks after receiving notification, an integrated response coordinating centre was set up by NCDC and requests for vaccines were sent to International Coordinating Group (ICG) on vaccine provision. While it took ICG one week to approve the requests, it took an average of two weeks for approximately 41% of requested vaccines to arrive. On the average, it took nine weeks from the date the epidemic threshold was crossed to commencement of reactive vaccination in the three states. Conclusion There were delays in detection and notification of the outbreak, in coordinating response activities, in requesting for vaccines and their arrival from ICG, and in initiating reactive vaccination. Reducing these delays in future outbreaks could help decrease the morbidity and mortality linked with meningococcal meningitis outbreaks.

[1]  F. Lessa,et al.  Meningitis Outbreak Caused by Vaccine-Preventable Bacterial Pathogens — Northern Ghana, 2016 , 2017, MMWR. Morbidity and mortality weekly report.

[2]  Kwame Acheampong,et al.  Descriptive Characterization of Epidemic Meningococcal Serogroup W in the Upper West Region of Ghana , 2017 .

[3]  G. Iliyasu,et al.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa , 2017, Pathogens and global health.

[4]  Sarah A. Meyer,et al.  Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data. , 2016, The Lancet. Infectious diseases.

[5]  Maleghemi Sylvester Toritseju,et al.  Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  O. Ronveaux,et al.  Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®. , 2015, Vaccine.

[7]  J. Alexander,et al.  Leadership transitions in multisectoral health care alliances: Implications for member perceptions of participation value , 2015, Health care management review.

[8]  F. Artal.  Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt. , 2015 .

[9]  J. Paireau,et al.  Analysing Spatio-Temporal Clustering of Meningococcal Meningitis Outbreaks in Niger Reveals Opportunities for Improved Disease Control , 2012, PLoS neglected tropical diseases.

[10]  N. Ravenscroft,et al.  Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. , 2009, Vaccine.

[11]  J. Chippaux.  Control of meningococcal meningitis outbreaks in sub-Saharan Africa. , 2008, Journal of infection in developing countries.

[12]  David L. Heymann,et al.  Global Surveillance, National Surveillance, and SARS , 2004, Emerging infectious diseases.

[13]  D. Heymann,et al.  Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. , 2002, Bulletin of the World Health Organization.

[14]  Rosamund F. Lewis,et al.  Timely detection of meningococcal meningitis epidemics in Africa , 2001, The Lancet.

[15]  A. Nasidi,et al.  A severe epidemic of meningococcal meningitis in Nigeria, 1996. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.